Amid the company's swirling legal problems, Columbia/HCA Healthcare Corp. released its second-quarter earnings report last week.
The company reported a 13% increase in net income for the second quarter ended June 30 to $412 million, or 62 cents per share, from about $364 million, or 54 cents per share, in the year-ago quarter. The Nashville-based company said revenues grew 5% to $5.2 billion.
For the six months, net income rose 14% to $891 million, or $1.32 per share, from $780 million, or $1.15 per share, in the year-ago period. Revenues rose 6.3% to $10.5 billion.
Although the earnings report was rosy, Columbia's stock price continued to slide.
The company's stock price dipped again last week after three of its executives were indicted. Columbia's stock closed at $32.50 on Aug. 1, down about 6% from the close on July 29, the day before the indictments were announced.